27239027|t|Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient -Specific Myoblasts Derived using a Human iPSC -Based Model
27239027|a|Duchenne muscular dystrophy (DMD) remains an intractable genetic disease. Althogh there are several animal models of DMD, there is no human cell model that carries patient -specific DYSTROPHIN mutations. Here, we present a human DMD model using human induced pluripotent stem cells (hiPSCs). Our model reveals concordant disease - related phenotypes with patient - dependent variation, which are partially reversed by genetic and pharmacological approaches. Our " chemical-compound -based" strategy successfully directs hiPSCs into expandable myoblasts, which exhibit a myogenic transcriptional program, forming striated contractile myofibers and participating in muscle regeneration in vivo. DMD - hiPSC -derived myoblasts show disease - related phenotypes with patient -to- patient variability, including aberrant expression of inflammation or immune-response genes and collagens, increased BMP / TGFβ signaling, and reduced fusion competence. Furthermore, by genetic correction and pharmacological "dual- SMAD " inhibition, the DMD - hiPSC -derived myoblasts and genetically corrected isogenic myoblasts form "rescued" multi - nucleated myotubes. In conclusion, our findings demonstrate the feasibility of establishing a human " DMD -in-a-dish" model using hiPSC -based disease modeling.
27239027	39	66	Duchenne Muscular Dystrophy	T038	UMLS:C0013264
27239027	85	94	Myoblasts	T017	UMLS:C0596995
27239027	111	116	Human	T204	UMLS:C0086418
27239027	117	121	iPSC	T017	UMLS:C2717959
27239027	129	134	Model	T038	UMLS:C0684309
27239027	135	162	Duchenne muscular dystrophy	T038	UMLS:C0013264
27239027	164	167	DMD	T038	UMLS:C0013264
27239027	192	207	genetic disease	T038	UMLS:C0019247
27239027	235	248	animal models	T038	UMLS:C0012644
27239027	252	255	DMD	T038	UMLS:C0013264
27239027	269	279	human cell	T017	UMLS:C0682523
27239027	317	327	DYSTROPHIN	T017	UMLS:C1414083
27239027	328	337	mutations	T038	UMLS:C0596611
27239027	358	363	human	T204	UMLS:C0086418
27239027	364	367	DMD	T038	UMLS:C0013264
27239027	368	373	model	T038	UMLS:C0684309
27239027	380	416	human induced pluripotent stem cells	T017	UMLS:C3658289
27239027	418	424	hiPSCs	T017	UMLS:C3658289
27239027	456	463	disease	T038	UMLS:C0012634
27239027	599	616	chemical-compound	T103	UMLS:C0220806
27239027	625	633	strategy	T062	UMLS:C0035171
27239027	655	661	hiPSCs	T017	UMLS:C3658289
27239027	678	687	myoblasts	T017	UMLS:C0596995
27239027	705	729	myogenic transcriptional	T038	UMLS:C0040649
27239027	756	767	contractile	T017	UMLS:C1752744
27239027	768	777	myofibers	T017	UMLS:C3179197
27239027	799	818	muscle regeneration	T033	UMLS:C1850849
27239027	819	826	in vivo	T082	UMLS:C1515655
27239027	828	831	DMD	T038	UMLS:C0013264
27239027	834	839	hiPSC	T017	UMLS:C3658289
27239027	849	858	myoblasts	T017	UMLS:C0596995
27239027	864	871	disease	T038	UMLS:C0012634
27239027	965	977	inflammation	T038	UMLS:C0021368
27239027	981	1002	immune-response genes	T017	UMLS:C0086344
27239027	1007	1016	collagens	T103	UMLS:C0009325
27239027	1028	1031	BMP	T038	UMLS:C1155364
27239027	1034	1048	TGFβ signaling	T038	UMLS:C1155363
27239027	1143	1147	SMAD	T103	UMLS:C1571580
27239027	1150	1160	inhibition	T038	UMLS:C1519312
27239027	1166	1169	DMD	T038	UMLS:C0013264
27239027	1172	1177	hiPSC	T017	UMLS:C3658289
27239027	1187	1196	myoblasts	T017	UMLS:C0596995
27239027	1232	1241	myoblasts	T017	UMLS:C0596995
27239027	1275	1283	myotubes	T017	UMLS:C0242697
27239027	1359	1364	human	T204	UMLS:C0086418
27239027	1367	1370	DMD	T038	UMLS:C0013264
27239027	1383	1388	model	T038	UMLS:C0684309
27239027	1395	1400	hiPSC	T017	UMLS:C3658289
27239027	1408	1424	disease modeling	T038	UMLS:C0684309